Sunlight exposure and risk of lens opacities in a population-based study: The Salisbury Eye Evaluation project

JAMA

Volumn 280, Issue 8, 1998, Pages 714-718

  West, Sheila K ^a   Duncan, Donald D ^a   Muñoz, Beatriz ^a   Rubin, Gary S ^a   Fried, Linda P ^a   Bandeen Roche, Karen ^a   Schein, Oliver D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CATARACT; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; POPULATION RESEARCH; PRIORITY JOURNAL; RADIATION EXPOSURE; RISK ASSESSMENT; SUN EXPOSURE; ULTRAVIOLET B RADIATION; UNITED STATES;

EID: 0032569246     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.8.714     Document Type: Article

References (34)

1. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Available data on blindness (update 1994). Ophthalmic Epidemiol. 1994;2:5-39.
2. Steinberg EP, Javitt JC, Sharkey PD, et al. The content and cost of cataract surgery. Arch Ophthalmol. 1993;111:1041-1049.
3. Sommer A, Tielsch J Katz J, et al. Racial differences in cause specific prevalence of blindness in East Baltimore. N Engl J Med. 1991;325:1412-1417.
4. Kupfer C. The conquest of cataract: a global challenge. Trans Am Ophthalmol Soc. 1984;104:1-10.
5. Taylor HR, West SK, Rosenthal FS, et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med. 1988;319:1429-1433.
6. Hollows F, Moran D. Cataract: the ultraviolet risk factor. Lancet. 1981;2:1249-1250.
7. Hiller R, Giacometti L, Yuen K. Sunlight and cataract: an epidemiological investigation. Am J Epidemiol. 1977;105:450-459.
8. Brilliant LB, Grasset NC, Pokhrel RP, et al. Associations among cataract prevalence, sunlight hours, and altitude in Himalayas. Am J Epidemiol. 1983;118:250-264.
9. Cruickshanks KJ, Klein BEK, Klein R. Ultraviolet light exposure and lens opacities: the Beaver Dam Eye Study. Am J Public Health . 1992;82:1658-1662.
10. Wong L, Ho SC, Coggon D, et al. Sunlight exposure, antioxidant status, and cataract in Hong Kong fishermen. J Epidemiol Community Health. 1993;47:46-49.
11. Rosini F, Stazi MA, Milton RC, Sperduto RD, Pasquini P, Maraini G. A dose-response effect between a sunlight index and age-related cataracts: Italian-American Cataract Study Group. Ann Epidemiol. 1994;4:266-270.
12. Dolezal J, Perkins E, Wallace R. Sunlight, skin sensitivity, and senile cataract. Am J Epidemiol. 1989;129:559-568.
13. Collman GW, Shore DL, Shy CM, Checkoway H, Luria AS. Sunlight and other risk factors for cataracts: an epidemiologic study. Am J Public Health. 1988;78:1459-1462.
14. Leske C, Chylack L, Wu S. The lens opacities case control study group. Arch Ophthalmol. 1991; 109:244-251.
15. West SK, Muñoz B, Schein OD, Duncan DD, Rubin GS. Racial differences in lens opacities: the SEE Project. Am J Epidemiol. In press.
16. Leske MC, Connell A, Wu S, et al. Prevalence of lens opacities in the Barbados Eye Study. Arch Ophthalmol. 1997;115:105-111.
17. Duncan DD, Muñoz B, Bandeen-Roche K, West SK. Visible and ultraviolet-B ocular ambient exposure ratios for a general population. Invest Ophthalmol Vis Sci. 1997;38:1003-1011.
18. Duncan DD, Schneider W, West KJ, Kirkpatrick SJ, West SK. The development of personal dosimeters for use in the visible and ultraviolet wavelength regions. Photochem Photobiol. 1995;62: 94-100.
19. Duncan DD, Muñoz B, Bandeen-Roche K, West SK. Assessment of ocular exposure to ultraviolet B for population studies. Photochem Photobiol. 1997; 66:701-709.
20. West SK, Muñoz B, Rubin GS, et al. Function and visual impairment in a population-based study of older adults: SEE Project. Invest Ophthalmol Vis Sci. 1997;38:72-82.
21. Hoover RN, Strasser PH. Artificial sweetness and human bladder cancer. Lancet. 1980;1:837-840.
22. Muñoz B, West SK, Rubin GS, Schein OD, Fried LP, Bandeen-Roche K. Who participates in population-based studies of visual impairment? the Salisbury Eye Evaluation Project experience. Ann Epidemiol. In press.
23. West SK, Rosenthal FS, Newland HS, Taylor HR. Use of photographic techniques to grade nuclear cataract. Invest Ophthalmol Vis Sci. 1988; 29:73-77.
24. West SK, Muñoz B, Wang F, Taylor H. Measuring progression of lens opacities for longitudinal studies. Curr Eye Res. 1993;12:123-132.
25. Bailey IL, Bullimore MA, Raasch TW, Taylor HR. Clinical grading and the effects of scaling. Invest Ophthalmol Vis Sci. 1991;32:422-432.
26. Rosenthal FS, Bakalian AE, Taylor HR. The effect of prescription eyewear on ocular exposure to ultraviolet radiation. Am J Public Health. 1986;76: 1216-1220.
27. Peters A, Davidson M, Schriger D, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. JAMA. 1996;276:1246-1252.
28. Smith AH, Waxweiler RJ, Tyroler HA. Epidemiologic investigation of occupational carcinogenesis using a serially additive expected dose model. Am J Epidemiol. 1980;112:787-797.
29. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HQ, Javitt J. Racial variations in the prevalence of primary open angle glaucoma: the Baltimore Eye Survey. JAMA. 1991;266:369-374.
30. Schachat AP, Hyman L, Leske MC, McConnell AM, Wu SY. Features of age-related macular degeneration in a black population: the Barbados Eye Study Group. Arch Ophthalmol. 1995;113:728-735.
31. Pitts DG, Cullen AP, Parr WH. Ocular Ultraviolet Effects From 295 nm in the Rabbit Eye. Cincinnati, Ohio: US Dept of Health, Education, and Welfare; 1976:1-55. NIOSH publication, No. 77-130.
32. Bochow TW, West SK, Azar A, Muñoz B, Sommer A, Taylor HR. Ultraviolet light exposure and risk of posterior subcapsular cataracts. Arch Ophthalmol. 1989;107:369-372.
33. Harding J. Cataract: Biochemistry, Epidemiology, and Pharmacology. London, England: Chapman & Hall; 1991.
34. Armitage P, Berry G. Statistical Methods in Medical Research. 2nd ed. Oxford, England: Blackwell Scientific Publications; 1985:469.